Profile

New User

New to Graphy Publications? Create an account to get started today.

Registered Users

Have an account? Sign in now.

How to Cite | Author Information | Publication History | Funding Information
International Journal of Clinical & Medical Microbiology Volume 1 (2016), Article ID 1:IJCMM-111, 5 pages
https://doi.org/10.15344/2456-4028/2016/111
Research Article
In Vitro Antifungal Activity of Cysteine Derivatives and their Combinations with Antifungal Agents Against Clinically Relevant Scedosporium species

László Galgóczy1,2*, Mónika Homa1, Tamás Papp1, Palanisamy Manikandan3,4 and Csaba Vágvölgyi1

1University of Szeged, Faculty of Science and Informatics, Department of Microbiology, Közép fasor 52, H-6726 Szeged, Hungary
2Medical University of Innsbruck, Biocenter, Division of Molecular Biology, Innrain 80-82, A-6020, Innsbruck, Austria
3Department of Microbiology and Molecular Biology, Aravind Eye Hospital and Postgraduate Institute of Ophthalmology, Coimbatore-641014, Tamilnadu, India
4College of Applied Medical Sciences, Majmaah University, Majmaah 11952, Kingdom of Saudi Arabia
Dr. László Galgóczy, Faculty of Science and Informatics, Department of Microbiology, Közép fasor 52, H-6726 Szeged, Hungary, Tel: +36 62 544005; E-mail: galgoczi@gmail.com
25 June 2016; 09 August 2016; 11 August 2016
Galgóczy L, Homa M, Papp T, Manikandan P, Vágvölgyi C (2016) In Vitro Antifungal Activity of Cysteine Derivatives and their Combinations with Antifungal Agents Against Clinically Relevant Scedosporium species. Int J Clin Med Microbiol 1: 111. doi: https://doi.org/10.15344/2456-4028/2016/111
The study was supported by the European Union co-financed by the European Social Fund (TÁMOP-4.2.2.B-15/1/KONV-2015-0006). This work was also funded by the grant LP2016-8/2016.
© 2016 Galgóczy et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

References

  1. Cortez KJ, Roilides E, Quiroz-Telles F, Meletiadis J, Antachopoulos C, et al. (2008) Infections caused by Scedosporium spp. Clin Microbiol Rev 21: 157-197 [CrossRef] [Google Scholar] [PubMed]
  2. Tortorano AM, Richardson M, Roilides E, van Diepeningen A, Caira M, et al. (2014) ESCMID and ECMM joint guidelines on diagnosis and management of hyalohyphomycosis: Fusarium spp., Scedosporium spp. and others. Clin Microbiol Infect 20: 27-46 [CrossRef] [Google Scholar] [PubMed]
  3. Alastruey-Izquierdo A, Mellado E, Peláez T, Pemán J, Zapico S, et al. (2013) Population-based survey of filamentous fungi and antifungal resistance in Spain (FILPOP Study). Antimicrob Agents Chemother 57: 3380-3387 [CrossRef] [Google Scholar] [PubMed]
  4. Guarro J, Kantarcioglu AS, Horré R, Rodriguez-Tudela JL, Cuenca Estrella M, et al. (2006) Scedosporium apiospermum: changing clinical spectrum of a therapy-refractory opportunist. Med Mycol 44: 295-327 [CrossRef] [Google Scholar] [PubMed]
  5. Octave S, Amborabé BE, Luini E, Ferreira T, Fleurat-Lessard P, Roblin G (2005) Antifungal effects of cysteine towards Eutypa lata, a pathogen of vineyards. Plant Physiol Biochem 43: 1006-1013 [CrossRef] [Google Scholar] [PubMed]
  6. Galgóczy L, Kovács L, Krizsán K, Papp T, Vágvölgyi C (2009) Inhibitory effects of cysteine and cysteine derivatives on germination of sporangiospores and hyphal growth of different Zygomycetes. Mycopathologia 168: 125-134 [CrossRef] [Google Scholar] [PubMed]
  7. Nguyen NT, Galgóczy J, Novák EK (1981) Morphogenetic effect of L-cysteine on dermatophytes. Acta Microbiol Acad Sci Hung 28: 347-357 [Google Scholar] [PubMed]
  8. Pandey DK, Chandra H, Tripathi NN, Dixit SN (1984) Antimycotic activity of some amino acids against dermatophytes. Arzneimittelforschung 34: 554- 556 [Google Scholar] [PubMed]
  9. Daigle DJ, Cotty PJ (1991) The influence of cysteine, cysteine analogs, and other amino acids on spore germination of Alternaria species. Can J Bot 69: 2353-2356 [CrossRef] [Google Scholar]
  10. Kahlos K, Tikka VH (1994) Antifungal activity of cysteine, its effect on C-21 oxygenated lanosterol derivatives and other lipids in Inonotus obliquus, in vitro. Appl Microbiol Biotechnol 42: 385-390 [CrossRef] [Google Scholar]
  11. De Lucca AJ, Walsh TJ, Daigle DJ (1996) N-acetylcysteine inhibits germination of conidia and growth of Aspergillus spp. and Fusarium spp. Antimicrob Agents Chemother 40: 1274-1276 [Google Scholar] [PubMed]
  12. Homa M, Galgóczy L, Tóth E, Virágh M, Chandrasekaran M, et al. (2016) In vitro susceptibility of Scedosporium isolates to N-acetyl-L-cysteine alone and in combination with conventional antifungal agents. Med Mycol [CrossRef] [Google Scholar] [PubMed]
  13. CLSI (2008) Reference method for broth dilution antifungal susceptibility testing of filamentous fungi. In: Approved standard CLSI document M38-A2. Wayne: Clinical and Laboratory Standards Institute, USA
  14. Homa M, Galgóczy L, Tóth E, Tóth L, Papp T, Chandrasekaran M, Kadaikunnan S, Alharbi NS, Vágvölgyi C (2015) In vitro antifungal activity of antipsychotic drugs and their combinations with conventional antifungals against Scedosporium and Pseudallescheria isolates. Med Mycol 53: 890- 895 [CrossRef] [Google Scholar] [PubMed]
  15. Eliopoulos GM, Moellering RC (1996) Antimicrobial combinations. In: Lorian V (Ed) Antibiotics in Laboratory Medicine (4th edn), Baltimore: The Williams and Wilkins Co., USA, 330-396 pp
  16. Johnson MD, MacDougall C, Ostrosky-Zeichner L, Perfect JR, Rex JH (2004) Combination antifungal therapy. Antimicrob Agents Chemother 48: 693-715 [CrossRef] [Google Scholar]
  17. Odds FC (2003) Synergy, antagonism, and what the chequerboard puts between them. J Antimicrob Chemother 52: 1 [CrossRef] [Google Scholar] [PubMed]
  18. Bekersky I, Fielding RM, Dressler DE, Lee JW, Buell DN, Walsh TJ (2002) Plasma protein binding of amphotericin B and pharmacokinetics of bound versus unbound amphotericin B after administration of intravenous liposomal amphotericin B (AmBisome) and amphotericin B deoxycholate. Antimicrob Agents Chemother 46: 834-840 [CrossRef] [Google Scholar] [PubMed]
  19. Nguyen TH, Hoppe-Tichy T, Geiss HK, Rastall AC, Swoboda S, et al. (2007) Factors influencing caspofungin plasma concentrations in patients of a surgical intensive care unit. J Antimicrob Chemother 60: 100-106 [CrossRef] [Google Scholar] [PubMed]
  20. Lewis RE (2008) What is the “therapeutic range” for voriconazole? Clin Infect Dis 46: 212-214 [CrossRef] [Google Scholar]
  21. Dolton MJ, Perera V, Pont LG, McLachlan AJ (2014) Terbinafine in combination with other antifungal agents for treatment of resistant or refractory mycoses: investigating optimal dosing regimens using a physiologically based pharmacokinetic model. Antimicrob Agents Chemother 58: 48-54 [CrossRef] [Google Scholar] [PubMed]
Best viewed in Mozilla Firefox, Google Chrome, Safari, Above IE 9.0 version
Privacy Policy | Copyright & Permissions
Copyright © 2013-2024 Graphy Publications, All Rights Reserved.